May 3 (Reuters) - Ambu A/S AMBUb.CO :
* INTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEAR
* OUTLOOK FY 2022/23: IS MAINTAINED
* QUARTER WAS DRIVEN BY CONTINUED STRONG GROWTH IN UROLOGY
AND
ENT, OFFSET BY PULMONOLOGY AND ANAESTHESIA
* Q2 ENDOSCOPY SOLUTIONS SALES FOR QUARTER WERE UP, WITH
ORGANIC
GROWTH OF 11% (3%), WHILE REPORTED GROWTH WAS 13% (7%), WITH
REVENUE OF DKK 663M
Source text for Eikon: ID:nGNE2nLf6z
Further company coverage: AMBUb.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))